$0.06
(Market cap
$71 Mln
Revenue (TTM)
$188 Mln
P/E Ratio
4.7
P/B Ratio
3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
23.01
-
EV/EBITDA
4.4
-
Debt to Equity
-1.8
-
Book Value
$--
-
EPS
$0.4
-
Face value
--
-
Shares outstanding
30,331,425
5 Years Aggregate
CFO
$103.23 Mln
EBITDA
$80.55 Mln
Net Profit
$87.71 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
biote Corp (BTMD)
| -16.7 | -1.1 | 2.1 | -37.4 | -26.2 | -26.1 | -- |
|
BSE Sensex
| -11.8 | -2.9 | -8.2 | -8.4 | 6.1 | 7.5 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
biote Corp (BTMD)
| -57.9 | 24.9 | 32.4 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
biote Corp (BTMD)
|
2.2 | 71.1 | 188.2 | 15.6 | 17.0 | -- | 4.7 | 3.0 |
| 1.3 | 160.1 | 318.8 | -85.7 | -15.2 | -64.2 | -- | 1.3 | |
| 39.8 | 984.9 | 771.4 | 34.9 | 7.9 | 8.7 | 28.8 | 2.6 | |
| 17.0 | 45.5 | 321.6 | 4.2 | 14.3 | -- | 10.3 | 7.0 | |
| 450.6 | 78,876.9 | 7,873.0 | 2,495.0 | 44.0 | 71.7 | 32.4 | 26.3 | |
| 184.5 | 6,921.9 | 2,508.4 | 402.8 | 23.1 | 31.8 | 18.6 | 6.6 | |
| 632.9 | 46,423.1 | 3,239.4 | 1,319.7 | 55.1 | -- | 36.5 | 37.6 | |
| 2.3 | 269.5 | 89.3 | -5.3 | -2.2 | -7.2 | -- | 3.6 | |
| 415.2 | 123,657.0 | 15,730.0 | 4,777.0 | 31.4 | 13.7 | 26.4 | 3.9 | |
| 32.2 | 302.3 | 33.8 | 22.0 | 14.3 | 20.9 | 13.8 | 2.8 |
Shareholding Pattern
View DetailsAbout biote Corp (BTMD)
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing... hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas. Read more
-
Executive Chairman
Mr. Marc D. Beer
-
Executive Chairman
Mr. Marc D. Beer
-
Headquarters
Irving, TX
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for biote Corp (BTMD)
What is the current share price of biote Corp (BTMD) Today?
The share price of biote Corp (BTMD) is $2.17 (NASDAQ) as of 02-Jun-2026 14:33 EDT. biote Corp (BTMD) has given a return of -26.22% in the last 3 years.
What is the current PB & PE ratio of biote Corp (BTMD)?
The P/E ratio of biote Corp (BTMD) is 4.65 times as on 29-May-2026, a 80 discount to its peers’ median range of 23.01 times.
The P/B ratio of biote Corp (BTMD) is 2.96 times as on 29-May-2026, a 43 discount to its peers’ median range of 5.16 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
3.56
|
-1.64
|
|
2024
|
66.56
|
-1.98
|
|
2023
|
38.73
|
-4.37
|
|
2022
|
-30.79
|
-0.67
|
|
2021
|
--
|
--
|
What is the 52 Week High and Low of biote Corp (BTMD)?
The 52-week high and low of biote Corp (BTMD) are Rs 4.75 and Rs 1.27 as of 03-Jun-2026.
What is the market cap of biote Corp (BTMD)?
biote Corp (BTMD) has a market capitalisation of $ 71 Mln as on 29-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in biote Corp (BTMD)?
Before investing in biote Corp (BTMD), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.